{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:22:37Z","timestamp":1771482157871,"version":"3.50.1"},"reference-count":136,"publisher":"Elsevier BV","issue":"9629","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/s0140-6736(08)60871-5","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T08:44:11Z","timestamp":1213433051000},"page":"2027-2038","source":"Crossref","is-referenced-by-count":184,"title":["Tobacco addiction"],"prefix":"10.1016","volume":"371","author":[{"given":"Dorothy K","family":"Hatsukami","sequence":"first","affiliation":[]},{"given":"Lindsay F","family":"Stead","sequence":"additional","affiliation":[]},{"given":"Prakash C","family":"Gupta","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(08)60871-5_bib1","series-title":"The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general","year":"2006"},{"key":"10.1016\/S0140-6736(08)60871-5_bib2","series-title":"The health consequences of smoking: a report of the surgeon general","year":"2004"},{"key":"10.1016\/S0140-6736(08)60871-5_bib3","series-title":"The tobacco atlas","author":"Mackay","year":"2006"},{"issue":"suppl","key":"10.1016\/S0140-6736(08)60871-5_bib4","first-page":"75","article-title":"Tobacco-dependence medications: public health and regulatory issues","volume":"53","author":"Henningfield","year":"1998","journal-title":"Food Drug Law J"},{"key":"10.1016\/S0140-6736(08)60871-5_bib5","series-title":"The health consequences of smoking: nicotine and addiction. A report of the surgeon general","year":"1988"},{"key":"10.1016\/S0140-6736(08)60871-5_bib6","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994"},{"key":"10.1016\/S0140-6736(08)60871-5_bib7","series-title":"International classification of diseases (ICD-10)","year":"1991"},{"key":"10.1016\/S0140-6736(08)60871-5_bib8","series-title":"Nicotine addiction in Britain: a report of the Tobacco Advisory Group of the Royal College of Physicians","year":"2000"},{"key":"10.1016\/S0140-6736(08)60871-5_bib9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2105\/AJPH.90.7.1122","article-title":"Predicting smoking cessation and major depression in nicotine-dependent smokers","volume":"90","author":"Breslau","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/S0140-6736(08)60871-5_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","article-title":"Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment","volume":"3","author":"Fagerstr\u00f6m","year":"1978","journal-title":"Addict Behav"},{"key":"10.1016\/S0140-6736(08)60871-5_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00846549","article-title":"Measuring nicotine dependence: a review of the Fagerstr\u00f6m tolerance questionnaire","volume":"12","author":"Fagerstr\u00f6m","year":"1989","journal-title":"J Behav Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstr\u00f6m tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br J Addict"},{"key":"10.1016\/S0140-6736(08)60871-5_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/14622200600672765","article-title":"Assessing tobacco dependence: a guide to measure evaluation and selection","volume":"8","author":"Piper","year":"2006","journal-title":"Nicotine Tob Res"},{"issue":"suppl 4","key":"10.1016\/S0140-6736(08)60871-5_bib14","first-page":"S555","article-title":"Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence","volume":"9","author":"Baker","year":"2007","journal-title":"Nic Tob Research"},{"key":"10.1016\/S0140-6736(08)60871-5_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","article-title":"Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day","volume":"84","author":"Heatherton","year":"1989","journal-title":"Br J Addict"},{"key":"10.1016\/S0140-6736(08)60871-5_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0095-4543(05)70120-2","article-title":"Nicotine addiction","volume":"26","author":"Benowitz","year":"1999","journal-title":"Prim Care"},{"key":"10.1016\/S0140-6736(08)60871-5_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0738-081X(98)00038-8","article-title":"Clinical pharmacology of nicotine","volume":"16","author":"Zevin","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1037\/0022-006X.61.5.743","article-title":"Nicotine delivery kinetics and abuse liability","volume":"61","author":"Henningfield","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.57.1.3","article-title":"Metabolism and disposition kinetics of nicotine","volume":"57","author":"Hukkanen","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/S0140-6736(08)60871-5_bib20","series-title":"Handbook of experimental pharmacology","first-page":"272","article-title":"Pharmalogical aspects of drug dependence: toward an integrated neurobehavioral approach","author":"Henningfield","year":"1996"},{"key":"10.1016\/S0140-6736(08)60871-5_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"6","author":"Paterson","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib22","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1523\/JNEUROSCI.22-09-03338.2002","article-title":"Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics","volume":"22","author":"Picciotto","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/S0140-6736(08)60871-5_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/14622200412331324965","article-title":"The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens","volume":"6","author":"Balfour","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/S0140-6736(08)60871-5_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(00)00042-8","article-title":"Long-term potentiation of excitatory inputs to brain reward areas by nicotine","volume":"27","author":"Mansvelder","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/S0140-6736(08)60871-5_bib26","doi-asserted-by":"crossref","first-page":"PL59","DOI":"10.1016\/S0024-3205(97)00444-X","article-title":"The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal","volume":"61","author":"Boyadjieva","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/S0140-6736(08)60871-5_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.coph.2004.12.002","article-title":"Nicotine: from molecular mechanisms to behaviour","volume":"5","author":"Wonnacott","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(02)00625-6","article-title":"Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas","volume":"33","author":"Mansvelder","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/S0140-6736(08)60871-5_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.10000","article-title":"Topiramate selectively attenuates nicotine-induced increases in monoamine release","volume":"42","author":"Schiffer","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/S0140-6736(08)60871-5_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(97)00101-5","article-title":"Regional variation in the effects of nicotine on catecholamine overflow in rat brain","volume":"325","author":"Benwell","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/BF01705545","article-title":"Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex","volume":"20","author":"Summers","year":"1995","journal-title":"Neurochem Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib32","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1523\/JNEUROSCI.21-22-08979.2001","article-title":"Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in vivo microdialysis study","volume":"21","author":"Fu","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/S0140-6736(08)60871-5_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/37120","article-title":"Nicotine activates and desensitizes midbrain dopamine neurons","volume":"390","author":"Pidoplichko","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(08)60871-5_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1476-5381.1995.tb13248.x","article-title":"Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine","volume":"114","author":"Benwell","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib36","first-page":"1175","article-title":"Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects","volume":"252","author":"Hughes","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib37","first-page":"21","article-title":"The nicotine withdrawal syndrome: a brief review and update","volume":"1","author":"Hughes","year":"1992","journal-title":"Int J Smoking Cessation"},{"key":"10.1016\/S0140-6736(08)60871-5_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1037\/0022-006X.70.1.142","article-title":"Mood disturbance fails to resolve across 31 days of cigarette abstinence in women","volume":"70","author":"Gilbert","year":"2002","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1360-0443.2002.00216.x","article-title":"Have we lost our way? The need for dynamic formulations of smoking relapse proneness","volume":"97","author":"Piasecki","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/S0140-6736(08)60871-5_bib40","series-title":"Research advances in alcohol and drug problems","first-page":"317","article-title":"Effects of abstinence from tobacco: a critical review","author":"Hughes","year":"1990"},{"key":"10.1016\/S0140-6736(08)60871-5_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0021-843X.112.1.3","article-title":"Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers","volume":"112","author":"Piasecki","year":"2003","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/0021-843X.109.1.74","article-title":"Smoking withdrawal dynamics in unaided quitters","volume":"109","author":"Piasecki","year":"2000","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1037\/0021-843X.112.1.14","article-title":"Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations","volume":"112","author":"Piasecki","year":"2003","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/1064-1297.5.2.137","article-title":"Craving is associated with smoking relapse: findings from three prospective studies","volume":"5","author":"Killen","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/0021-843X.107.2.238","article-title":"Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms","volume":"107","author":"Piasecki","year":"1998","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1037\/0021-843X.115.3.454","article-title":"Life before and after quitting smoking: an electronic diary study","volume":"115","author":"McCarthy","year":"2006","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-4603(90)90013-N","article-title":"Postcessation cigarette use: the process of relapse","volume":"15","author":"Brandon","year":"1990","journal-title":"Addict Behav"},{"key":"10.1016\/S0140-6736(08)60871-5_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1037\/0278-6133.15.6.455","article-title":"Temptations to smoke after quitting: a comparison of lapsers and maintainers","volume":"15","author":"Shiffman","year":"1996","journal-title":"Health Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-005-0250-x","article-title":"Nicotine and nonnicotine factors in cigarette addiction","volume":"184","author":"Rose","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S0140-6736(08)60871-5_bib50","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1176\/appi.ajp.162.8.1414","article-title":"Addiction: a disease of learning and memory","volume":"162","author":"Hyman","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0140-6736(08)60871-5_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0091-3057(01)00676-1","article-title":"Cue dependency of nicotine self-administration and smoking","volume":"70","author":"Caggiula","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/S0140-6736(08)60871-5_bib52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0031-9384(02)00918-6","article-title":"Importance of nonpharmacological factors in nicotine self-administration","volume":"77","author":"Caggiula","year":"2002","journal-title":"Physiol Behav"},{"key":"10.1016\/S0140-6736(08)60871-5_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00213-002-1156-5","article-title":"Environmental stimuli promote the acquisition of nicotine self-administration in rats","volume":"163","author":"Caggiula","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S0140-6736(08)60871-5_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00213-003-1473-3","article-title":"Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement","volume":"169","author":"Donny","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S0140-6736(08)60871-5_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-005-0178-1","article-title":"Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement","volume":"184","author":"Chaudhri","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S0140-6736(08)60871-5_bib56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-005-0183-4","article-title":"Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers","volume":"184","author":"Palmatier","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"suppl 2","key":"10.1016\/S0140-6736(08)60871-5_bib57","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1080\/14622299050011811","article-title":"The genetic epidemiology of smoking","volume":"1","author":"Sullivan","year":"1999","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib58","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1038\/sj.onc.1205801","article-title":"Applying genetic approaches to the treatment of nicotine dependence","volume":"21","author":"Lerman","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/S0140-6736(08)60871-5_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14622200410001734030","article-title":"The genetic basis for smoking behavior: a systematic review and meta-analysis","volume":"6","author":"Munafo","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/hmg\/ddl438","article-title":"Cholinergic nicotinic receptor genes implicated in nicotine dependence association study targeting 348 candidate genes with 3713 SNPs","volume":"16","author":"Saccone","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0140-6736(08)60871-5_bib61","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib62","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0140-6736(08)60871-5_bib63","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","article-title":"Smoking, smoking cessation, and major depression","volume":"264","author":"Glassman","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib64","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1991.01810360033005","article-title":"Nicotine dependence, major depression, and anxiety in young adults","volume":"48","author":"Breslau","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0140-6736(08)60871-5_bib65","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1360-0443.1994.tb00960.x","article-title":"DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders","volume":"89","author":"Breslau","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/S0140-6736(08)60871-5_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14622200110050457","article-title":"The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being","volume":"3","author":"Degenhardt","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0376-8716(01)00126-0","article-title":"Comorbidity between patterns of substance use dependence and psychiatric syndromes","volume":"64","author":"Kandel","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S0140-6736(08)60871-5_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.drugalcdep.2004.06.004","article-title":"Smoking, nicotine dependence and psychiatric comorbidity\u2014a population-based study including smoking cessation after three years","volume":"76","author":"John","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S0140-6736(08)60871-5_bib69","series-title":"Treaing tobacco use and dependence 2008 update: clinical guideline","author":"Fiore","year":"2008"},{"key":"10.1016\/S0140-6736(08)60871-5_bib70","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thorax.55.12.987","article-title":"Smoking cessation guidelines for health professionals: an update. Health Education Authority","volume":"55","author":"West","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/S0140-6736(08)60871-5_bib72","first-page":"642","article-title":"Cigarette smoking among adults\u2014United States, 2000","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S0140-6736(08)60871-5_bib73","series-title":"Smoking-related behaviour and attitudes","author":"Taylor","year":"2005"},{"key":"10.1016\/S0140-6736(08)60871-5_bib74","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.1990.03440200064024","article-title":"Methods used to quit smoking in the United States. Do cessation programs help?","volume":"263","author":"Fiore","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000165.pub2","article-title":"Physician advice for smoking cessation","volume":"4","author":"Lancaster","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(08)60871-5_bib76","series-title":"Morbidity statistics from general practice; 4th national study 1991\u201392. OPCS Series MB5\/3","first-page":"29","year":"1995"},{"key":"10.1016\/S0140-6736(08)60871-5_bib77","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1001\/jama.288.14.1768","article-title":"Effective tobacco dependence treatment","volume":"288","author":"Fiore","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib78","series-title":"The health benefits of smoking cessation. A report of the surgeon general. Report number DHHS publication number (CDC) 90-8416","year":"1990"},{"key":"10.1016\/S0140-6736(08)60871-5_bib79","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1378\/chest.97.3.547","article-title":"The older smoker. Status, challenges and opportunities for intervention","volume":"97","author":"Rimer","year":"1990","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(08)60871-5_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002850.pub2","article-title":"Telephone counselling for smoking cessation","volume":"3","author":"Stead","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl","key":"10.1016\/S0140-6736(08)60871-5_bib81","first-page":"1","article-title":"Tobacco use prevention and control","volume":"20","year":"2001","journal-title":"Am J Prev Med"},{"issue":"suppl","key":"10.1016\/S0140-6736(08)60871-5_bib82","first-page":"1","article-title":"Introducing the guide to community preventive services","volume":"18","year":"2000","journal-title":"Am J Prev Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib83","series-title":"AHFS Drug Information","year":"2004"},{"key":"10.1016\/S0140-6736(08)60871-5_bib84","series-title":"Physicians' desk reference","year":"2006"},{"key":"10.1016\/S0140-6736(08)60871-5_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/pcad.2003.YPCAD14","article-title":"Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease","volume":"45","author":"Joseph","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S0140-6736(08)60871-5_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000031.pub3","article-title":"Antidepressants for smoking cessation","volume":"1","author":"Hughes","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(08)60871-5_bib87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5414\/CPP41056","article-title":"Bupropion: pharmacological and clinical profile in smoking cessation","volume":"41","author":"Haustein","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib88","author":"Tatley"},{"key":"10.1016\/S0140-6736(08)60871-5_bib89","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-3565(24)37887-5","article-title":"Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine","volume":"287","author":"Benowitz","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000146.pub2","article-title":"Nicotine replacement therapy for smoking cessation","volume":"3","author":"Silagy","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(08)60871-5_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub2","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"1","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(08)60871-5_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000058.pub2","article-title":"Clonidine for smoking cessation","volume":"3","author":"Gourlay","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(08)60871-5_bib93","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.159.17.2033","article-title":"Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler","volume":"159","author":"Hajek","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib94","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/thx.2007.078758","article-title":"Is nicotine replacement therapy for smoking cessation effective in the \u201creal world\u201d? Findings from a prospective multinational cohort study","volume":"62","author":"West","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/S0140-6736(08)60871-5_bib95","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archinte.162.11.1267","article-title":"Efficacy of a nicotine lozenge for smoking cessation","volume":"162","author":"Shiffman","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/tc.12.1.21","article-title":"A meta-analysis of the efficacy of over-the-counter nicotine replacement","volume":"12","author":"Hughes","year":"2003","journal-title":"Tob Control"},{"key":"10.1016\/S0140-6736(08)60871-5_bib97","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.288.10.1260","article-title":"Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation","volume":"288","author":"Pierce","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib98","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1001\/jama.288.24.3109-JLT1225-1-4","article-title":"Effectiveness of over-the-counter nicotine replacement therapy","volume":"288","author":"Stead","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib99","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.288.24.3108","article-title":"Effectiveness of over-the-counter nicotine replacement therapy","volume":"288","author":"Franzon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)37928-5","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine","volume":"288","author":"Fryer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib101","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archpsyc.59.10.930","article-title":"Psychological intervention and antidepressant treatment in smoking cessation","volume":"59","author":"Hall","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0140-6736(08)60871-5_bib102","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pupt.2005.05.003","article-title":"A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results","volume":"19","author":"Haggstram","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib103","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/archinte.165.19.2286","article-title":"Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease","volume":"165","author":"Wagena","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib104","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib107","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib108","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib109","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1185\/030079907X182185","article-title":"A double-blind study evaluating the long-term safety of varenicline for smoking cessation","volume":"23","author":"Williams","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S0140-6736(08)60871-5_bib110","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/archinte.164.16.1797","article-title":"Bupropion for smoking cessation: a randomized trial","volume":"164","author":"Simon","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib111","doi-asserted-by":"crossref","unstructured":"Evins AE, Cather C, Culhane M, et al A placebo-controlled study of bupropion sr added to high dose nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Society for Research on Nicotine and Tobacco 12th annual meeting; Feb 15\u201318, 2006; Orlando, Florida.","DOI":"10.1097\/01.jcp.0b013e3180ca86fa"},{"key":"10.1016\/S0140-6736(08)60871-5_bib112","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1037\/0022-006X.72.4.729","article-title":"Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers","volume":"72","author":"Killen","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib113","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.164.20.2229","article-title":"A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation","volume":"164","author":"Prochazka","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib114","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1176\/appi.ajp.161.11.2100","article-title":"Extended nortriptyline and psychological treatment for cigarette smoking","volume":"161","author":"Hall","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0140-6736(08)60871-5_bib115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-135-6-200109180-00011","article-title":"Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial","volume":"135","author":"Hays","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(08)60871-5_bib116","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.2003.08.160","article-title":"Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking","volume":"21","author":"Hurt","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib117","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/0022-006X.74.2.286","article-title":"Extended treatment with bupropion SR for cigarette smoking cessation","volume":"74","author":"Killen","year":"2006","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0025-6196(11)60997-X","article-title":"Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention","volume":"82","author":"Croghan","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S0140-6736(08)60871-5_bib119","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.311.7001.363","article-title":"Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers","volume":"311","author":"Gourlay","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(08)60871-5_bib121","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1360-0443.1993.tb02060.x","article-title":"Recycling with nicotine patches in smoking cessation","volume":"88","author":"Tonnesen","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/S0140-6736(08)60871-5_bib122","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/mcp.2001.115750","article-title":"Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study","volume":"69","author":"Gonzales","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1360-0443.2004.00576.x","article-title":"Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy","volume":"99","author":"Shiffman","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/S0140-6736(08)60871-5_bib124","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5993\/AJHB.26.3.6","article-title":"Impact of prior nicotine replacement therapy on smoking cessation efficacy","volume":"26","author":"Durcan","year":"2002","journal-title":"Am J Health Behav"},{"key":"10.1016\/S0140-6736(08)60871-5_bib125","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1360-0443.2005.01174.x","article-title":"The feasibility of smoking reduction: an update","volume":"100","author":"Hughes","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/S0140-6736(08)60871-5_bib126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jnci\/djh016","article-title":"Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen","volume":"96","author":"Hecht","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(08)60871-5_bib127","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1378\/chest.128.4.2528","article-title":"Effects of cigarette reduction on cardiovascular risk factors and subjective measures","volume":"128","author":"Hatsukami","year":"2005","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(08)60871-5_bib128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jech.57.6.412","article-title":"Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976\u20131998: a pooled cohort study","volume":"57","author":"Godtfredsen","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S0140-6736(08)60871-5_bib129","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/thorax.57.11.967","article-title":"Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study","volume":"57","author":"Godtfredsen","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/S0140-6736(08)60871-5_bib130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/jama.294.12.1505","article-title":"Effect of smoking reduction on lung cancer risk","volume":"294","author":"Godtfredsen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(08)60871-5_bib131","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14622200600789726","article-title":"Does smoking reduction increase future cessation and decrease disease risk? A qualitative review","volume":"8","author":"Hughes","year":"2006","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/S0140-6736(08)60871-5_bib132","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1567-5769(03)00094-8","article-title":"Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats","volume":"3","author":"Satoskar","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib133","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clpt.2005.08.007","article-title":"Safety and immunogenicity of a nicotine conjugate vaccine in current smokers","volume":"78","author":"Hatsukami","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0140-6736(08)60871-5_bib134","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behav Pharmacol"},{"key":"10.1016\/S0140-6736(08)60871-5_bib135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.npp.1300541","article-title":"Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)","volume":"30","author":"Cohen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S0140-6736(08)60871-5_bib136","unstructured":"Cinciripini PM, Aubin H-J, Dale LC, Niaura R, Anthenelli RM, Stratus Group. Pooled analysis of three short-term, randomised, double-blind, placebo controlled trials with Rimonabant 20 mg\/day in smoking cessation. 8th annual conference of the Society on Research on Nicotine and Tobacco Europe; Sept 23\u201326, 2006; Kusadasi, Turkey."},{"key":"10.1016\/S0140-6736(08)60871-5_bib137","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","article-title":"Shape of the relapse curve and long-term abstinence among untreated smokers","volume":"99","author":"Hughes","year":"2004","journal-title":"Addiction"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673608608715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673608608715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:11:05Z","timestamp":1738260665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673608608715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":136,"journal-issue":{"issue":"9629","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0140673608608715"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(08)60871-5","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}